Besides LRP1B mutations associating with prognosis/survival in cancer patients, including GB [9,11,21,22], LRP1B mutations have been associated with higher tumor mutation burden (TMB) and better prognosis in lung cancer and melanoma patients [10]. This evidence concerns the gene LRP1B and cancer.